share_log

Piper Sandler Initiates Coverage On Galera Therapeutics With Overweight Rating, Announces Price Target of $6

Benzinga Real-time News ·  Feb 21, 2023 05:07

Piper Sandler analyst Edward Tenthoff initiates coverage on Galera Therapeutics (NASDAQ:GRTX) with a Overweight rating and announces Price Target of $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment